Julie Butters Selected Research

CER-001

1/2018	Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
6/2017	Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden.
2/2017	Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Butters Research Topics

Disease

7	Atherosclerotic Plaque (Atheroma) 12/2022 - 02/2017
6	Acute Coronary Syndrome 12/2022 - 02/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2017
4	Carcinoma (Carcinomatosis) 05/2016 - 11/2006
3	Atherosclerosis 01/2018 - 02/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 09/2020
2	Myocardial Infarction 12/2022 - 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	AIDS-Related Complex (ARC) 01/2022
1	Disease Progression 02/2021
1	Dyslipidemias (Dyslipidemia) 09/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Inflammation (Inflammations) 01/2018
1	Proctitis 12/2012
1	Neoplasms (Cancer) 11/2006

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 12/2022 - 12/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2018
3	CER-001IBA 01/2018 - 02/2017
3	HDL LipoproteinsIBA 01/2018 - 02/2017
2	evolocumabIBA 01/2022 - 02/2021
1	Colchicine FDA LinkGeneric 12/2022
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2022
1	SubtilisinIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Proprotein Convertase 9IBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	CholesterolIBA 01/2018
1	SphingomyelinsIBA 02/2017
1	Pre-beta High-Density LipoproteinsIBA 02/2017
1	Carisoprodol (Soma)FDA LinkGeneric 11/2006

Therapy/Procedure

4	Radiotherapy 05/2016 - 11/2006
1	Therapeutics 12/2022
1	Intravenous Infusions 01/2018